Michael Buschle

3.6k total citations
50 papers, 2.8k citations indexed

About

Michael Buschle is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Michael Buschle has authored 50 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 21 papers in Molecular Biology and 16 papers in Genetics. Recurrent topics in Michael Buschle's work include Immunotherapy and Immune Responses (22 papers), Virus-based gene therapy research (14 papers) and RNA Interference and Gene Delivery (9 papers). Michael Buschle is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Virus-based gene therapy research (14 papers) and RNA Interference and Gene Delivery (9 papers). Michael Buschle collaborates with scholars based in Austria, Germany and United States. Michael Buschle's co-authors include Malcolm K. Brenner, Wolfgang Zauner, Ernst Wagner, Dario Campana, Alexander von Gabain, D. Rill, Max L. Birnstiel, Matthew Cotten, A. V. Hoffbrand and Walter Schmidt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Michael Buschle

49 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Buschle Austria 27 1.3k 1.0k 637 580 472 50 2.8k
Reiko Namikawa United States 26 661 0.5× 1.8k 1.8× 602 0.9× 592 1.0× 549 1.2× 51 3.5k
Helen Tighe United States 25 1.2k 0.9× 3.0k 2.9× 385 0.6× 238 0.4× 371 0.8× 43 4.8k
Gayle C. Bosma United States 21 1.3k 1.0× 2.3k 2.3× 562 0.9× 254 0.4× 768 1.6× 42 4.2k
Robert W. Tindle Australia 29 738 0.6× 1.5k 1.4× 402 0.6× 329 0.6× 494 1.0× 79 2.8k
R Risser United States 27 1.4k 1.1× 731 0.7× 839 1.3× 185 0.3× 572 1.2× 57 2.9k
John P. Atkinson United States 20 447 0.3× 2.3k 2.2× 261 0.4× 512 0.9× 227 0.5× 23 3.1k
Jos Even France 32 903 0.7× 3.2k 3.1× 410 0.6× 491 0.8× 1.3k 2.8× 73 4.5k
Claudia Benike United States 28 1.6k 1.3× 4.9k 4.8× 335 0.5× 575 1.0× 1.8k 3.8× 50 6.3k
Richard Rudersdorf United States 25 659 0.5× 1.4k 1.3× 203 0.3× 617 1.1× 154 0.3× 32 2.7k
M Lieberman United States 20 573 0.4× 1.3k 1.3× 629 1.0× 332 0.6× 427 0.9× 42 2.5k

Countries citing papers authored by Michael Buschle

Since Specialization
Citations

This map shows the geographic impact of Michael Buschle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Buschle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Buschle more than expected).

Fields of papers citing papers by Michael Buschle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Buschle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Buschle. The network helps show where Michael Buschle may publish in the future.

Co-authorship network of co-authors of Michael Buschle

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Buschle. A scholar is included among the top collaborators of Michael Buschle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Buschle. Michael Buschle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klade, Christoph, Heiner Wedemeyer, Thomas Berg, et al.. (2008). Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41. Gastroenterology. 134(5). 1385–1395.e1. 123 indexed citations
2.
Schellack, Carola, Alena Egyed, Jörg H. Fritz, et al.. (2006). IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine. 24(26). 5461–5472. 132 indexed citations
3.
Bruña–Romero, Oscar, John Schmieg, Margarita Del Val, Michael Buschle, & Moriya Tsuji. (2003). The Dendritic Cell-Specific Chemokine, Dendritic Cell-Derived CC Chemokine 1, Enhances Protective Cell-Mediated Immunity to Murine Malaria. The Journal of Immunology. 170(6). 3195–3203. 27 indexed citations
4.
Henics, Tamás, Birgit Winkler, Ulrike Pfeifer, et al.. (2003). Small-fragment genomic libraries for the display of putative epitopes from clinically significant pathogens. BioTechniques. 35(1). 196–209. 16 indexed citations
5.
Bello-Fernández, C, Jana Stasakova, Nicole Carballido‐Perrig, et al.. (2003). Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties. Blood. 101(6). 2184–2190. 12 indexed citations
6.
Minh, Duc Bui, Tamás Henics, Birgit Winkler, et al.. (2002). Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proceedings of the National Academy of Sciences. 99(10). 6573–6578. 173 indexed citations
7.
Marschütz, Michaela K., et al.. (2002). Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration. Peptides. 23(10). 1727–1733. 23 indexed citations
9.
Riedl, Petra, Michael Buschle, Jörg Reimann, & Reinhold Schirmbeck. (2002). Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants. European Journal of Immunology. 32(6). 1709–1709. 33 indexed citations
10.
Zauner, Wolfgang, Karen Lingnau, Frank Mattner, Alexander von Gabain, & Michael Buschle. (2001). Defined Synthetic Vaccines. Biological Chemistry. 382(4). 581–95. 21 indexed citations
11.
Laufer, Günther, Helga Bergmeister, Michael Buschle, et al.. (1999). Modified technique of delivering solutions to rat coronary arteries in the transplant setting. Transplantation Proceedings. 31(8). 3255–3256. 1 indexed citations
12.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1997). Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine. 75(4). 297–299. 11 indexed citations
13.
Schweighoffer, Tamás, Wolfgang Schmidt, Michael Buschle, & Max L. Birnstiel. (1996). Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines.. PubMed. 3(9). 819–24. 11 indexed citations
14.
Zatloukal, Kurt, Achim Schneeberger, M Berger, et al.. (1995). Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.. The Journal of Immunology. 154(7). 3406–3419. 76 indexed citations
15.
Rill, D., Michael Buschle, Nicholas K. Foreman, et al.. (1992). Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow Transplantation. Human Gene Therapy. 3(2). 129–136. 45 indexed citations
16.
Gignac, Suzanne M., Michael Buschle, A. V. Hoffbrand, & Hans G. Drexler. (1990). Down‐regulation of CD5 mRNA in B‐chronic lymphocytic leukemia cells by differentiation‐inducing agents. European Journal of Immunology. 20(5). 1119–1123. 5 indexed citations
17.
Gignac, Suzanne M., Michael Buschle, R. Michael Roberts, et al.. (1990). Differential expression of TRAP Isoenzyme in B-CLL Cells Treated with Different Inducers. Leukemia & lymphoma. 3(1). 19–29. 7 indexed citations
18.
Gignac, Suzanne M., Michael Buschle, Helen E. Heslop, et al.. (1990). Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor. Leukemia & lymphoma. 3(1). 37–43. 5 indexed citations
19.
Buschle, Michael, et al.. (1989). ras Gene Mutations and Clonal Analysis Using RFLPs of X-chromosome Genes in Myelodysplastic Syndromes. Hämatologie und Bluttransfusion. 32. 386–389. 1 indexed citations
20.
Bartram, Claus R., W.-D. Ludwig, W. Hiddemann, et al.. (1989). Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.. PubMed. 3(4). 247–56. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026